XML 38 R54.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 28, 2020
Mar. 30, 2019
Measured on a recurring basis | Level 3    
Contingent Consideration    
Beginning balance $ 11.9 $ 15.3
Changes in value 1.1 1.2
Settlements and other adjustments 0.0 (4.1)
Ending balance 13.0 12.4
Royalty Pharma Contingent Milestone Payments    
Royalty Pharma Contingent Milestone Payments    
Payments received   (250.0)
Royalty Pharma Contingent Milestone Payments | Measured on a recurring basis | Level 3    
Royalty Pharma Contingent Milestone Payments    
Beginning balance 95.3 323.2
Payments received 0.0 (250.0)
Change in fair value   10.4
Ending balance $ 96.9 $ 83.6